Ruth M Ayling
Overview
Explore the profile of Ruth M Ayling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ayling R, Cotter F
BMJ Open Gastroenterol
. 2024 Sep;
11(1).
PMID: 39284679
Objective: Colorectal cancer (CRC) is the fourth most common cancer in the UK. Patients with symptoms suggestive of CRC should be referred for urgent investigation. However, gastrointestinal symptoms are often...
2.
Zaloum S, Paris A, Mair D, Gutteridge C, Ayling R, Onen B, et al.
BMJ Neurol Open
. 2024 Jun;
6(1):e000737.
PMID: 38835539
Introduction: Cases of nitrous oxide (NO)-induced myeloneuropathy are increasing at UK hospitals. At our centre, a dedicated ambulatory care pathway, endorsed nationally, was established to treat and monitor patients with...
3.
Murray J, Kok K, Ayling R
Clin Chem
. 2023 May;
69(7):699-710.
PMID: 37228058
Background: Inflammatory bowel disease (IBD) comprises a group of chronic conditions characterized by relapsing and remitting inflammation of the gastrointestinal tract. The incidence is increasing worldwide, and the therapeutic options...
4.
Ayling R, Machesney M
J Clin Pathol
. 2023 Apr;
77(7):495-499.
PMID: 37072172
Aim: Colorectal cancer (CRC) is the fourth most common cancer in the UK. Following National Institute for Health and Care Excellence guidance for faecal immunochemical testing (FIT), we introduced a...
5.
Bath M, Malhi A, Ayling R, Seward E, Pritchard-Jones K, Laszlo H, et al.
BJS Open
. 2023 Mar;
7(2).
PMID: 36884345
Background: Measurement of faecal haemoglobin using faecal immunochemistry testing is recommended in patients presenting with symptoms suspicious for colorectal cancer, to aid in triage and prioritization of definitive investigations. While...
6.
Paris A, Lake L, Joseph A, Workman A, Walton J, Hayton T, et al.
Pract Neurol
. 2023 Feb;
23(3):222-228.
PMID: 36813556
Recreational use of nitrous oxide (NO) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has...
7.
Butenas J, Ayling R
Clin Chem Lab Med
. 2022 Sep;
60(11):1780-1785.
PMID: 36087065
Objectives: Faecal calprotectin (f-Cal) and faecal haemoglobin (f-Hb) are important tests for evaluation of gastrointestinal disease. Samples for measurement of f-Hb are taken by the patient directly into a specimen...
8.
Waite M, Langmead L, Ayling R
Ann Clin Biochem
. 2021 Dec;
59(3):171-177.
PMID: 34958262
Objective: NICE recommends measurement of faecal haemoglobin (f-Hb) using faecal immunochemical test (FIT) when colorectal cancer is suspected and calprotectin (f-Cal) in the context of inflammatory bowel disease, though neither...
9.
Laszlo H, Seward E, Ayling R, Lake J, Malhi A, Stephens C, et al.
Br J Cancer
. 2021 Dec;
126(5):736-743.
PMID: 34903843
Background: We evaluated whether faecal immunochemical testing (FIT) can rule out colorectal cancer (CRC) among patients presenting with 'high-risk' symptoms requiring definitive investigation. Methods: Three thousand five hundred and ninety-six...
10.
Ayling R, Wong A, Cotter F
BMJ Open Gastroenterol
. 2021 Jun;
8(1).
PMID: 34083226
Objective: Colorectal cancer (CRC) is the fourth most common cancer in UK. Symptomatic patients are referred via an urgent pathway and although most are investigated with colonoscopy <4% are diagnosed...